Atlas Trials

A Study to Evaluate SAGE-217 in Participants With Bipolar I/II Disorder With a Current Major Depressive Episode

Clinical trial NCT03692910 · COMPLETED

Trial details

NCT number
NCT03692910
Sponsor
Biogen
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Bipolar Disorder IBipolar Disorder IIMajor Depressive Episode
Start date
2018-08-23
Primary completion
2019-05-21
Enrollment
35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.